159 related articles for article (PubMed ID: 17897122)
1. Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy.
Chalil S; Stegemann B; Muhyaldeen SA; Khadjooi K; Foley PW; Smith RE; Leyva F
Pacing Clin Electrophysiol; 2007 Oct; 30(10):1201-9. PubMed ID: 17897122
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
[TBL] [Abstract][Full Text] [Related]
3. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.
Chalil S; Stegemann B; Muhyaldeen S; Khadjooi K; Smith RE; Jordan PJ; Leyva F
J Am Coll Cardiol; 2007 Jul; 50(3):243-52. PubMed ID: 17631217
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy in patients with mildly impaired left ventricular function.
Foley PW; Stegemann B; Smith RE; Sanderson JE; Leyva F
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S186-9. PubMed ID: 19250090
[TBL] [Abstract][Full Text] [Related]
5. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population.
Foley PW; Chalil S; Khadjooi K; Smith RE; Frenneaux MP; Leyva F
Europace; 2008 Nov; 10(11):1302-7. PubMed ID: 18827063
[TBL] [Abstract][Full Text] [Related]
7. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy.
Chalil S; Foley PW; Muyhaldeen SA; Patel KC; Yousef ZR; Smith RE; Frenneaux MP; Leyva F
Europace; 2007 Nov; 9(11):1031-7. PubMed ID: 17933857
[TBL] [Abstract][Full Text] [Related]
8. Functional behavior of patients with conventional pacemakers undergoing cardiac resynchronization.
Silva RT; Martinelli Filho M; Lima CE; Martins DG; Nishióka SA; Pedrosa AA; Crevelari ES; Costa R; Sosa EA; Ramires JA
Arq Bras Cardiol; 2008 Feb; 90(2):138-43. PubMed ID: 18392387
[TBL] [Abstract][Full Text] [Related]
9. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
[TBL] [Abstract][Full Text] [Related]
10. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
[TBL] [Abstract][Full Text] [Related]
11. The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy.
Riedlbauchová L; Brunken R; Jaber WA; Popová L; Patel D; Lánská V; Civello K; Cummings J; Burkhardt JD; Saliba W; Martin D; Schweikert R; Wilkoff BL; Grimm R; Natale A
J Cardiovasc Electrophysiol; 2009 Jan; 20(1):50-7. PubMed ID: 18803571
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
[TBL] [Abstract][Full Text] [Related]
13. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
[TBL] [Abstract][Full Text] [Related]
14. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
[TBL] [Abstract][Full Text] [Related]
15. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
16. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
[TBL] [Abstract][Full Text] [Related]
18. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
[TBL] [Abstract][Full Text] [Related]
19. Six-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapy.
Castel MA; Méndez F; Tamborero D; Mont L; Magnani S; Tolosana JM; Berruezo A; Godoy M; Sitges M; Vidal B; Roig E; Brugada J
Europace; 2009 Mar; 11(3):338-42. PubMed ID: 19136491
[TBL] [Abstract][Full Text] [Related]
20. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease.
Kwong RY; Chan AK; Brown KA; Chan CW; Reynolds HG; Tsang S; Davis RB
Circulation; 2006 Jun; 113(23):2733-43. PubMed ID: 16754804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
